[go: up one dir, main page]

PE18095A1 - 3-bencilaminometil piperidinas sustituidas con heteroarilamino y heteroarilsulfonamido y compuestos afines - Google Patents

3-bencilaminometil piperidinas sustituidas con heteroarilamino y heteroarilsulfonamido y compuestos afines

Info

Publication number
PE18095A1
PE18095A1 PE1994249628A PE24962894A PE18095A1 PE 18095 A1 PE18095 A1 PE 18095A1 PE 1994249628 A PE1994249628 A PE 1994249628A PE 24962894 A PE24962894 A PE 24962894A PE 18095 A1 PE18095 A1 PE 18095A1
Authority
PE
Peru
Prior art keywords
alkyl
heteroarilsulfonamido
heteroarilamino
bencilaminometil
related compounds
Prior art date
Application number
PE1994249628A
Other languages
English (en)
Inventor
Jr Harry R Howard
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PE18095A1 publication Critical patent/PE18095A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA I DONDE: 1) A ES UN ARILO COMO FENILO, NAFTILO, TIENILO, DIHIDROQUINOLINILO, INDOLINILO; 2) P ES NR2, O, S, SO, SO2; 3) Q ES SO2, NH, -N(ENLACE A A)-ALQUILO C1-C6, ALQUILO C1-C6-N(ENLACE A A)-SO2-; 4) W ES H, ALQUILO C1-C6, S-ALQUILO C1-C3, HALOGENO, ALCOXI C1-C6; 5) R1 ES UN ANILLO HETEROCICLICO COMO TIAZOLILO, PIRROLILO, TIENILO, TRIAZOLILO, OXAZOLILO, OXADIAZOLILO, TIADIAZOLILO, IMIDAZOLILO, LOS CUALES PUEDEN ESTAR SUSTITUIDOS; 6) R2 ES H, -CO2-ALQUILO C1-C10; 7) R3 ES UN ANILLO HETEROCICLICO QUE CONTIENE NITROGENO; EL CUAL ES ANTAGONISTA DE LA SUSTANCIA P QUE ES UN NEUROPEPTIDO
PE1994249628A 1993-09-17 1994-09-01 3-bencilaminometil piperidinas sustituidas con heteroarilamino y heteroarilsulfonamido y compuestos afines PE18095A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12330693A 1993-09-17 1993-09-17

Publications (1)

Publication Number Publication Date
PE18095A1 true PE18095A1 (es) 1995-07-03

Family

ID=22407886

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1994249628A PE18095A1 (es) 1993-09-17 1994-09-01 3-bencilaminometil piperidinas sustituidas con heteroarilamino y heteroarilsulfonamido y compuestos afines

Country Status (9)

Country Link
US (1) US5703065A (es)
EP (2) EP1209157A1 (es)
JP (1) JP2963200B2 (es)
AU (1) AU7082194A (es)
EC (1) ECSP941156A (es)
FI (1) FI944310A7 (es)
IL (1) IL110931A0 (es)
PE (1) PE18095A1 (es)
WO (1) WO1995007908A1 (es)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10508837A (ja) * 1994-11-10 1998-09-02 ファイザー・インコーポレーテッド 眼の疾患を治療するためのｎｋ−１レセプターアンタゴニスト
IL116249A (en) * 1994-12-12 2003-07-06 Pfizer Nk-1 receptor antagonists for the treatment of neuronal damage and stroke
JP3041051B2 (ja) * 1995-10-10 2000-05-15 ファイザー・インコーポレーテッド 遺伝子治療における神経性炎症の予防のためのｎｋ−１レセプターアンタゴニスト
WO2001032625A1 (en) 1999-11-03 2001-05-10 Du Pont Pharmaceuticals Company Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
US7163949B1 (en) 1999-11-03 2007-01-16 Amr Technology, Inc. 4-phenyl substituted tetrahydroisoquinolines and use thereof
CA2415532C (en) 2000-07-11 2010-05-11 Albany Molecular Research, Inc. Novel 4-phenyl substituted tetrahydroisoquinolines therapeutic use thereof
AU2001288972A1 (en) * 2000-09-11 2002-03-26 Sepracor, Inc. Antipsychotic sulfonamide-heterocycles, and methods of use thereof
IL158990A0 (en) * 2001-07-20 2004-05-12 Pfizer Prod Inc Use of nk-1 receptor antagonists to modify unwanted behavior in dogs, cats and horses
UA91341C2 (ru) 2004-07-15 2010-07-26 Амр Текнолоджи, Інк. Арил- и гетероарилзамещенные тетрагидроизохинолины и их применение для блокирования обратного захвата норэпинефрина, допамина и серотонина
WO2006123182A2 (en) 2005-05-17 2006-11-23 Merck Sharp & Dohme Limited Cyclohexyl sulphones for treatment of cancer
NZ565111A (en) 2005-07-15 2011-10-28 Amr Technology Inc Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
WO2007041052A2 (en) 2005-09-29 2007-04-12 Merck & Co., Inc. Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
GB0603041D0 (en) 2006-02-15 2006-03-29 Angeletti P Ist Richerche Bio Therapeutic compounds
WO2008039327A2 (en) 2006-09-22 2008-04-03 Merck & Co., Inc. Method of treatment using fatty acid synthesis inhibitors
US20110218176A1 (en) 2006-11-01 2011-09-08 Barbara Brooke Jennings-Spring Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
EP2805945B1 (en) 2007-01-10 2019-04-03 MSD Italia S.r.l. Amide substituted indazoles as poly(ADP-ribose)polymerase (PARP) inhibitors
JP5319518B2 (ja) 2007-04-02 2013-10-16 Ｍｓｄ株式会社 インドールジオン誘導体
AU2008269154B2 (en) 2007-06-27 2014-06-12 Merck Sharp & Dohme Llc 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
CA2717509A1 (en) 2008-03-03 2009-09-11 Tiger Pharmatech Tyrosine kinase inhibitors
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
US8691825B2 (en) 2009-04-01 2014-04-08 Merck Sharp & Dohme Corp. Inhibitors of AKT activity
EP2429295B1 (en) 2009-05-12 2013-12-25 Albany Molecular Research, Inc. Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
EA020553B1 (ru) 2009-05-12 2014-12-30 Олбани Молекьюлар Рисерч, Инк. 7-([1,2,4]ТРИАЗОЛО[1,5-α]ПИРИДИН-6-ИЛ)-4-(3,4-ДИХЛОРФЕНИЛ)-1,2,3,4-ТЕТРАГИДРОИЗОХИНОЛИН, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ЕГО ОСНОВЕ И СПОСОБЫ ЛЕЧЕНИЯ НЕВРОЛОГИЧЕСКИХ И ПСИХИЧЕСКИХ РАССТРОЙСТВ
KR20120023072A (ko) 2009-05-12 2012-03-12 브리스톨-마이어스 스큅 컴퍼니 （Ｓ）-7-（〔1,2,4〕트리아졸〔1,5-ａ〕피리딘-6-일）-4-（3,4-디클로로페닐）-1,2,3,4-테트라하이드로이소퀴놀린의 결정형 및 이의 용도
CN102638981B (zh) 2009-10-14 2015-07-22 默沙东公司 提高p53活性的取代的哌啶和其用途
US8999957B2 (en) 2010-06-24 2015-04-07 Merck Sharp & Dohme Corp. Heterocyclic compounds as ERK inhibitors
EP2601293B1 (en) 2010-08-02 2017-12-06 Sirna Therapeutics, Inc. RNA INTERFERENCE MEDIATED INHIBITION OF CATENIN (CADHERIN-ASSOCIATED PROTEIN), BETA 1 (CTNNB1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO2012024170A2 (en) 2010-08-17 2012-02-23 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS B VIRUS (HBV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
EP2608669B1 (en) 2010-08-23 2016-06-22 Merck Sharp & Dohme Corp. NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
WO2012030685A2 (en) 2010-09-01 2012-03-08 Schering Corporation Indazole derivatives useful as erk inhibitors
US9242981B2 (en) 2010-09-16 2016-01-26 Merck Sharp & Dohme Corp. Fused pyrazole derivatives as novel ERK inhibitors
EP3766975A1 (en) 2010-10-29 2021-01-20 Sirna Therapeutics, Inc. Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
WO2012087772A1 (en) 2010-12-21 2012-06-28 Schering Corporation Indazole derivatives useful as erk inhibitors
IN2013MN02170A (es) 2011-04-21 2015-06-12 Piramal Entpr Ltd
US9023865B2 (en) 2011-10-27 2015-05-05 Merck Sharp & Dohme Corp. Compounds that are ERK inhibitors
EP3919620A1 (en) 2012-05-02 2021-12-08 Sirna Therapeutics, Inc. Short interfering nucleic acid (sina) compositions
RU2660429C2 (ru) 2012-09-28 2018-07-06 Мерк Шарп И Доум Корп. Новые соединения, которые являются ингибиторами erk
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
HK1209742A1 (en) 2012-11-20 2016-04-08 沃泰克斯药物股份有限公司 Compounds useful as inhibitors of indoleamine 2,3-dioxygenase
PL2925888T3 (pl) 2012-11-28 2018-03-30 Merck Sharp & Dohme Corp. Kompozycje i sposoby do stosowania w leczeniu nowotworów
KR102196882B1 (ko) 2012-12-20 2020-12-30 머크 샤프 앤드 돔 코포레이션 Hdm2 억제제로서의 치환된 이미다조피리딘
WO2014120748A1 (en) 2013-01-30 2014-08-07 Merck Sharp & Dohme Corp. 2,6,7,8 substituted purines as hdm2 inhibitors
US20160194368A1 (en) 2013-09-03 2016-07-07 Moderna Therapeutics, Inc. Circular polynucleotides
EP3525785B1 (en) 2016-10-12 2025-08-27 Merck Sharp & Dohme LLC Kdm5 inhibitors
US10947234B2 (en) 2017-11-08 2021-03-16 Merck Sharp & Dohme Corp. PRMT5 inhibitors
EP3706747B1 (en) 2017-11-08 2025-09-03 Merck Sharp & Dohme LLC Prmt5 inhibitors
WO2020033284A1 (en) 2018-08-07 2020-02-13 Merck Sharp & Dohme Corp. Prmt5 inhibitors
EP3833668B1 (en) 2018-08-07 2025-03-19 Merck Sharp & Dohme LLC Prmt5 inhibitors
MA53287A (fr) 2018-08-07 2022-05-11 Merck Sharp & Dohme Inhibiteurs de prmt5
CN113527418B (zh) * 2021-07-16 2022-05-03 成都普康唯新生物科技有限公司 一种ADC linker的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234946A (en) * 1987-11-27 1993-08-10 Banyu Pharmaceutical Co., Ltd. Substituted alkylamine derivatives
UA41251C2 (uk) * 1990-01-04 2001-09-17 Пфайзер, Інк. Гідровані азотвмісні гетероциклічні сполуки, похідні піперидину, фармацевтична композиція та спосіб пригнічення активності речовини р в організмі
US5232929A (en) * 1990-11-28 1993-08-03 Pfizer Inc. 3-aminopiperidine derivatives and related nitrogen containing heterocycles and pharmaceutical compositions and use
US5773450A (en) * 1991-06-20 1998-06-30 Pfizer Inc. Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
EP1114823A3 (en) * 1992-08-19 2001-07-18 Pfizer Inc. Substituted benzylamino nitrogen containing non-aromatic heterocycles
JP2722279B2 (ja) * 1992-12-10 1998-03-04 ファイザー・インク． アミノメチレンで置換した非芳香族複素環式化合物及びサブスタンスｐのアンタゴニストとしての使用
US5340826A (en) * 1993-02-04 1994-08-23 Pfizer Inc. Pharmaceutical agents for treatment of urinary incontinence
ES2087813B1 (es) * 1993-08-09 1997-02-01 Pfizer Heterociclos no-aromaticos que contienen nitrogeno bencilamino substituidos.

Also Published As

Publication number Publication date
US5703065A (en) 1997-12-30
JPH08509987A (ja) 1996-10-22
JP2963200B2 (ja) 1999-10-12
AU7082194A (en) 1995-04-03
WO1995007908A1 (en) 1995-03-23
FI944310L (fi) 1995-03-18
IL110931A0 (en) 1994-11-28
EP1209157A1 (en) 2002-05-29
FI944310A0 (fi) 1994-09-16
EP0719266A1 (en) 1996-07-03
FI944310A7 (fi) 1995-03-18
ECSP941156A (es) 1995-02-27

Similar Documents

Publication Publication Date Title
PE18095A1 (es) 3-bencilaminometil piperidinas sustituidas con heteroarilamino y heteroarilsulfonamido y compuestos afines
PE17995A1 (es) Antagonista triciclico de vasopresina de benzacepina
ATE407924T1 (de) Stickstoffhaltige, fünfgliedrige ringverbindungen
AR014110A1 (es) Compuestos de 2-aminopiridinas, composiciones farmaceuticas, procedimiento de tratamiento, prevencion e inhibicion
CY1106534T1 (el) Αρωματικες εξαμελεις κυκλικες ενωσεις που περιεχουν αζωτο
ES2182485T3 (es) Derivados de aminofenil isosazolina sustituidos utiles como agentes antimicrobianos.
ID29452A (id) 4-okso-1,4-dihidro-3-quinolinkarboksamida sebagai agen-agen antivirus
PT1052254E (pt) Derivados heterocíclicos azotados e medicamento dos mesmos
SE8802926L (sv) Estrar och amider av cykliska karboxylsyror och cykliska alkoholer och aminer
ES2194346T3 (es) Compuestos que contienen boro y aluminio.
BG102792A (bg) Производни на заместени 4-хидроксифенилалканоилови киселини с агонистична активност към рраr-гама
ES2058809T3 (es) Derivados heterociclicos.
PE2799A1 (es) Lactamas e imidas heterociclicas de aralquilo y aralquilideno
DK0444659T3 (da) Farmaceutisk opløsning indeholdende derivater af FK 506
DK0625977T3 (da) Piperazinderivater som 5-1A-antagonister
ES2055705T3 (es) Fungicidas.
DK464288D0 (da) Carbamoylpyrrolidonderivater
NO180196C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive amino- og nitroholdige, tricykliske forbindelser
ES2177058T3 (es) Compuestos eter piperidinilaminometil trifluorometil ciclicos como antagonistas de la sustancia p.
AR245933A1 (es) Procedimiento para preparar compuestos de 4-(3-hidroxifenil)metil-3-alquil-n-alquilpiperidina y sus sales.
PT94297A (pt) Processo para a preparacao de n-hetero-aril-purin-6-aminas e de composicoes farmaceuticas que as contem
ES2060583T3 (es) Nuevos derivados de cefalosporina, procedimiento para su obtencion y preparados farmaceuticos correspondientes.
MX9504800A (es) Derivados de acido nipecotico como compuestos antitromboticos.
ES2093091T3 (es) Derivado de glutation.
ES8706690A1 (es) Un procedimiento para la preparacion de nuevos derivados de penem.

Legal Events

Date Code Title Description
FD Application declared void or lapsed